Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
Recruiting
N/A
Interventional Study
NAFLD
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 35 – 40
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 8 (estimated)
- Sponsor
- Steno Diabetes Center Copenhagen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators will conduct a proof-of-principle 4-weeks low-calorie diet (LCD) intervention study in low birth weight (LBW) subjects and normal birth weight (NBW) controls with documented (MR scan) liver fat content equal to or above 5%. The investigators will provide extended in-depth mechanistic insight into the role of impaired subcutaneous adipose tissue (SAT) expandability in ectopic fat …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* subjects with NAFLD (liver fat content ≥5% liver fat content verified on MRS in the screening NAFLD study)
Exclusion Criteria:
* BMI\<18.5 and BMI\>30 kg/m2
* Family history of diabetes (siblings, parent, and grandparents)
* Disease/medication known to affect primary outcome…
Contacts